Free Trial

Charles River Laboratories International (CRL) Competitors

$208.44
-1.28 (-0.61%)
(As of 05/31/2024 ET)

CRL vs. A, MTD, WAT, ILMN, TECH, BRKR, BIO, PACB, HBIO, and LIFE

Should you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bruker (BRKR), Bio-Rad Laboratories (BIO), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and aTyr Pharma (LIFE). These companies are all part of the "life sciences tools & services" industry.

Charles River Laboratories International vs.

Charles River Laboratories International (NYSE:CRL) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, community ranking, dividends, earnings, analyst recommendations, valuation and risk.

Agilent Technologies has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charles River Laboratories International$4.13B2.60$474.62M$8.5024.52
Agilent Technologies$6.83B5.59$1.24B$4.2330.83

Agilent Technologies has a net margin of 18.84% compared to Charles River Laboratories International's net margin of 10.81%. Agilent Technologies' return on equity of 26.25% beat Charles River Laboratories International's return on equity.

Company Net Margins Return on Equity Return on Assets
Charles River Laboratories International10.81% 15.16% 6.60%
Agilent Technologies 18.84%26.25%14.45%

Agilent Technologies received 373 more outperform votes than Charles River Laboratories International when rated by MarketBeat users. Likewise, 71.70% of users gave Agilent Technologies an outperform vote while only 61.51% of users gave Charles River Laboratories International an outperform vote.

CompanyUnderperformOutperform
Charles River Laboratories InternationalOutperform Votes
481
61.51%
Underperform Votes
301
38.49%
Agilent TechnologiesOutperform Votes
854
71.70%
Underperform Votes
337
28.30%

Charles River Laboratories International has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500.

In the previous week, Agilent Technologies had 30 more articles in the media than Charles River Laboratories International. MarketBeat recorded 43 mentions for Agilent Technologies and 13 mentions for Charles River Laboratories International. Charles River Laboratories International's average media sentiment score of 0.38 beat Agilent Technologies' score of 0.22 indicating that Charles River Laboratories International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Charles River Laboratories International
2 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Agilent Technologies
9 Very Positive mention(s)
1 Positive mention(s)
11 Neutral mention(s)
7 Negative mention(s)
0 Very Negative mention(s)
Neutral

98.9% of Charles River Laboratories International shares are held by institutional investors. 1.3% of Charles River Laboratories International shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Charles River Laboratories International currently has a consensus price target of $255.27, indicating a potential upside of 22.47%. Agilent Technologies has a consensus price target of $137.19, indicating a potential upside of 5.20%. Given Charles River Laboratories International's stronger consensus rating and higher possible upside, research analysts plainly believe Charles River Laboratories International is more favorable than Agilent Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charles River Laboratories International
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64
Agilent Technologies
1 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.56

Summary

Agilent Technologies beats Charles River Laboratories International on 11 of the 18 factors compared between the two stocks.

Get Charles River Laboratories International News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRL vs. The Competition

MetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE Exchange
Market Cap$10.74B$5.52B$5.12B$17.81B
Dividend YieldN/A1.20%2.75%3.55%
P/E Ratio24.5221.93167.0325.81
Price / Sales2.6079.892,426.9711.39
Price / Cash12.4816.1235.2018.95
Price / Book2.943.755.535.90
Net Income$474.62M$143.48M$106.01M$976.46M
7 Day Performance-4.04%3.82%1.14%0.62%
1 Month Performance-10.42%23.14%1.43%4.79%
1 Year Performance6.16%-5.34%4.07%24.00%

Charles River Laboratories International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
A
Agilent Technologies
4.5668 of 5 stars
$145.48
-1.8%
$141.06
-3.0%
+12.2%$42.63B$6.83B34.6418,100Earnings Report
Analyst Forecast
Short Interest ↓
Analyst Revision
News Coverage
MTD
Mettler-Toledo International
3.5425 of 5 stars
$1,440.54
-1.0%
$1,257.14
-12.7%
+5.7%$30.77B$3.79B40.4017,300Analyst Revision
Positive News
WAT
Waters
3.8457 of 5 stars
$327.65
-1.3%
$305.78
-6.7%
+20.6%$19.44B$2.96B32.157,900Insider Buying
Analyst Revision
ILMN
Illumina
4.702 of 5 stars
$101.76
-3.1%
$164.65
+61.8%
-47.6%$16.21B$4.49B-12.499,300Short Interest ↑
TECH
Bio-Techne
4.0197 of 5 stars
$78.60
-1.0%
$81.00
+3.1%
-5.5%$12.39B$1.14B62.383,200
BRKR
Bruker
4.9382 of 5 stars
$72.55
-4.4%
$85.00
+17.2%
-7.7%$10.54B$2.96B26.389,707Short Interest ↑
BIO
Bio-Rad Laboratories
4.7924 of 5 stars
$284.94
-0.4%
$461.00
+61.8%
-22.8%$8.13B$2.67B-27.508,030Analyst Upgrade
Short Interest ↓
Analyst Revision
News Coverage
PACB
Pacific Biosciences of California
2.8785 of 5 stars
$1.82
-2.7%
$6.59
+262.1%
-86.1%$495.70M$200.52M-1.60796Gap Down
HBIO
Harvard Bioscience
1.0309 of 5 stars
$3.10
-2.5%
N/A-44.3%$134.63M$112.25M-15.50391Short Interest ↓
LIFE
aTyr Pharma
3.2678 of 5 stars
$1.68
-6.1%
$23.67
+1,308.7%
-23.8%$115.94M$350,000.00-1.8756Short Interest ↓
Positive News

Related Companies and Tools

This page (NYSE:CRL) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners